Detalle de: Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma
| Title | Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma |
| Abstract | |
| Apa Reference | Lanillos, J., Santos, M., Valdivia, C., Mora, A. & Rodríguez-Antona, C. (2022). Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma. European Urology, 82(3), 334-335. 10.1016/j.eururo.2022.05.013 |
| Doi | 10.1016/j.eururo.2022.05.013 |
| Publication Date | Sep 2022 |
| Publication Type | Article |
| Researcher | María Santos Romero |
| Ontology | |
| Research Groups | |
| Tools |